Dementia and cognitive function and its treatment

html xmlns=”http://www.w3.org/1999/xhtml” xmlns:mml=”http://www.w3.org/1998/Math/MathML” xmlns:epub=”http://www.idpf.org/2007/ops”>


9 Dementia and cognitive function and its treatment




Question One




Mary, a 79-year-old patient, is brought to your office by her daughter, who reports that her mother has been exhibiting several concerning symptoms over the past year. Comprehensive questioning reveals that her symptoms are: trouble remembering familiar things, such as telephone numbers commonly dialed; not recognizing some close family members who visit often; moodiness; and difficulty performing writing tasks. Although not definitive, these symptoms are most likely indicative of which type of dementia?




A. Alzheimer’s disease



B. Dementia with Lewy bodies



C. Huntington’s disease



D. Frontotemporal dementia



Answer to Question One


The correct answer is A.























Choice Peer answers
A. Alzheimer’s disease 89%
B. Dementia with Lewy bodies 2%
C. Huntington’s disease 0%
D. Frontotemporal dementia 10%

Differential diagnosis of dementias can be difficult, as all are characterized by the core symptom of memory impairment. However, it may be possible to distinguish dementias clinically through other presenting symptoms.




A Correct. In addition to memory impairment, Alzheimer’s disease consists of deficits in language (aphasia), motor function (apraxia), recognition (agnosia), or executive functioning, all of which this patient exhibits. Definitive diagnosis, however, is not possible until autopsy.



B Incorrect. Dementia with Lewy bodies is often accompanied by extrapyramidal symptoms, which this patient does not have.



C Incorrect. Huntington’s disease is associated with spasmodic movements and incoordination, which are also absent in this patient.



D Incorrect. In frontotemporal dementia, patients often are disinhibited and may be extremely talkative, symptoms that are also not part of this patient’s presentation.



References


Schatzberg AF, Nemeroff CB. Textbook of psychopharmacology, fourth edition. Washington, DC: American Psychiatric Publishing, Inc.; 2009. (Chapter 48)

Stahl SM. Stahl’s essential psychopharmacology, fourth edition. New York, NY: Cambridge University Press; 2013. (Chapter 13)


Question Two




A young man who is pre-med and has a family history of Alzheimer’s disease is interested in learning more about the brain regions involved in memory and the development of Alzheimer’s disease. You describe the pathways of acetylcholine, an important neurotransmitter involved in dementia. As part of your explanation, you tell him that major cholinergic projections stem from the _____ to the _____, which are believed to be involved in memory.




A. Basal forebrain; nucleus accumbens



B. Basal forebrain; prefrontal cortex



C. Striatum; hypothalamus



D. Striatum; prefrontal cortex



Answer to Question Two


The correct answer is B.























Choice Peer answers
A. Basal forebrain; nucleus accumbens 7%
B. Basal forebrain; prefrontal cortex 59%
C. Striatum; hypothalamus 15%
D. Striatum; prefrontal cortex 16%



A, C, and D Incorrect.



B Correct. Acetylcholine is an important neurotransmitter, and is thought to be involved in memory. Major acetylcholine neurotransmitter projections originating in the basal forebrain project to the prefrontal cortex, hippocampus, and amygdala.



References


Schatzberg AF, Nemeroff CB. Textbook of psychopharmacology, fourth edition. Washington, DC: American Psychiatric Publishing, Inc.; 2009. (Chapter 48)

Stahl SM. Stahl’s essential psychopharmacology, fourth edition. New York, NY: Cambridge University Press; 2013. (Chapter 13)

Woolf NJ, Butcher LL. Cholinergic systems mediate action from movement to higher consciousness. Behav Brain Res 2011;221(2):488–98.


Question Three




A young woman brings her 72-year-old mother for an appointment because she is concerned that her mother may have Alzheimer’s disease. The mother does not feel that anything is wrong, but her daughter states that she has seemed somewhat depressed and forgetful lately. Data have shown that:




A. Depression is often comorbid with Alzheimer’s disease



B. Depression may increase the risk of developing Alzheimer’s disease



C. Depression may be a prodromal symptom of Alzheimer’s disease



D. All of the above



E. None of the above



Answer to Question Three


The correct answer is D.


























Choice Peer answers
A. Depression is often comorbid with Alzheimer’s disease 2%
B. Depression may increase the risk of developing Alzheimer’s disease 2%
C. Depression may be a prodromal symptom of Alzheimer’s disease 6%
D. All of the above 88%
E. None of the above 2%



A Partially correct. Mood symptoms can occur as part of Alzheimer’s disease and in fact are typically the first notable symptom (often manifested as apathy rather than sadness). In addition, depression is a common comorbid illness in patients with Alzheimer’s disease.



B Partially correct. Depression has been hypothesized to be a possible risk factor for Alzheimer’s disease.



C Partially correct. Depression has been hypothesized to be a possible prodromal symptom of Alzheimer’s disease, with some evidence suggesting that it may exacerbate the progression of Alzheimer’s pathology.



D Correct (all of the above).



E Incorrect (none of the above).



References


Barnes DE, Yaffe K, Byers AL, et al. Midlife vs late-life depressive symptoms and risk of dementia: differential effects for Alzheimer disease and vascular dementia. Arch Gen Psychiatry 2012;69(5):493–8.

Pomara N, Bruno D, Sarreal AS, et al. Lower CSF amyloid beta peptides and higher F2-isoprostanes in cognitively intact elderly individuals with major depressive disorder. Am J Psychiatry 2012;169:523–30.


Question Four




A 68-year-old patient with an early diagnosis of Alzheimer’s disease is put on a cholinesterase inhibitor in hopes of improving his cognitive function. This patient has been a chain smoker for over 40 years and refuses to give up the habit. Which of the following medications would not be appropriate for this patient, given his smoking habit?




A. Donepezil



B. Galantamine



C. Rivastigmine



D. None of these medications should be prescribed to a patient who smokes



E. There are no contraindications due to smoking for these medications



Answer to Question Four


The correct answer is E.


























Choice Peer answers
A. Donepezil 0%
B. Galantamine 22%
C. Rivastigmine 4%
D. None of these medications should be prescribed to a patient who smokes 4%
E. There are no contraindications due to smoking for these medications 71%



E Correct. One can potentially choose any cholinesterase inhibitor as a first-line treatment, since specific contraindications due to smoking do not presently appear in the literature.



A Incorrect. Donepezil, a reversible, long-acting selective inhibitor of acetylcholinesterase (AChE), may be a good choice, resulting in mainly transient gastrointestinal side effects.



B Incorrect. Galantamine has a dual mechanism of action: AChE inhibition and positive allosteric modulation (PAM) of nicotinic cholinergic receptors. This may be a good choice for this patient.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Mar 19, 2017 | Posted by in PSYCHIATRY | Comments Off on Dementia and cognitive function and its treatment

Full access? Get Clinical Tree

Get Clinical Tree app for offline access